Cagrilintide 5 mg – Research Peptide

SKU: CGL5
CAS Number: 1415456-99-3
Specification: 5 mg/vial
Package Size: 10 vials/kit
Form: Lyophilized powder
Intended Use: Laboratory research only

Product Overview

Cagrilintide is a synthetic, lipidated, long-acting amylin analogue developed for scientific research involving amylin-receptor signaling, metabolic regulation, appetite-related pathways and energy-balance mechanisms.

Amylin is a pancreatic peptide hormone associated with satiety and the regulation of food intake. Cagrilintide has been engineered to provide a longer duration of activity than native amylin and is being investigated in clinical research both independently and in combination with semaglutide.

Cagrilintide is described in scientific literature as an agonist of amylin receptors and the calcitonin receptor. It is intended for qualified laboratory and analytical research only.

This product is not a medicine, food, dietary supplement or cosmetic product. It is not intended for human or veterinary use.

Key Product Features

• Long-acting synthetic amylin analogue

• Research-grade peptide material

• Supplied as lyophilized powder

• 5 mg of Cagrilintide per vial

• 10 individually sealed vials per kit

• Suitable for laboratory and analytical research

• Batch-specific quality documentation available

• Secure professional packaging for international shipment

Product Specifications

Research Applications

Cagrilintide may be used by qualified research organizations for studies involving:

• Amylin receptor signaling

• Calcitonin receptor signaling

• Appetite and satiety mechanisms

• Food-intake regulation pathways

• Energy-balance research

• Body-weight regulation mechanisms

• Glucose-metabolism research

• Metabolic-health research

• Peptide pharmacology

• Long-acting peptide analogue development

• Combination-pathway research involving amylin and GLP-1 systems

Any proposed application must be reviewed and conducted by qualified professionals under appropriate institutional, laboratory and regulatory controls.

Mechanism of Interest

Cagrilintide is a long-acting analogue of amylin, a hormone naturally co-secreted with insulin by pancreatic beta cells.

In research models, amylin-related signaling is associated with:

• Increased satiety signaling

• Regulation of food intake

• Modulation of gastric-emptying pathways

• Energy-balance regulation

• Metabolic signaling

Cagrilintide has been designed through peptide modification and lipidation to extend its duration of activity compared with native amylin.

It is being studied as a standalone investigational compound and as one component of CagriSema, an investigational combination of cagrilintide and semaglutide.

Quality Documentation

Batch-specific quality documents may include:

• Certificate of Analysis

• HPLC analytical report

• Mass-spectrometry report

• Batch number

• Manufacturing date

• Retest or expiry information

• Storage recommendations

Purity and analytical specifications should always be confirmed using the Certificate of Analysis supplied with the individual batch.

Packaging

Each kit contains:

• 10 individually sealed Cagrilintide vials

• 5 mg of lyophilized material per vial

• Protective internal vial tray

• Outer product box

• Batch identification

• Secure shipping packaging

Packaging design or vial appearance may vary between manufacturing batches without affecting the stated product specification.

Storage and Handling

Store unopened lyophilized material according to the temperature and handling conditions stated on the product label and batch-specific Certificate of Analysis.

General laboratory handling recommendations:

• Keep the product sealed until required for research.

• Protect the material from direct light.

• Protect the material from moisture.

• Avoid unnecessary temperature fluctuations.

• Use appropriate personal protective equipment.

• Handle only in a suitably equipped laboratory.

• Prevent cross-contamination between samples.

• Follow institutional procedures for peptide handling and disposal.

Storage conditions must be confirmed against the batch-specific Certificate of Analysis. Do not publish a fixed shelf life unless it has been verified by the manufacturer.

Safety Information

Cagrilintide is an investigational research compound.

• For laboratory research use only

• Not for human use

• Not for veterinary use

• Not for diagnostic use

• Not for therapeutic use

• Not for household use

• Not for use as food, medicine, supplement or cosmetic

• Not intended for compounding, dispensing or administration

The purchaser is responsible for ensuring that the product is handled by trained personnel and used in accordance with applicable laws, institutional policies and laboratory safety requirements.

Regulatory Disclaimer

This product is offered exclusively as a research material. It has not been evaluated or approved as a finished pharmaceutical product.

Information on this page is provided for product identification and scientific reference only. It must not be interpreted as medical advice, prescribing information, a therapeutic recommendation or a claim of clinical efficacy.

The buyer is responsible for confirming whether the purchase, importation, possession and use of this material are permitted within the relevant jurisdiction.

Frequently Asked Questions

What is Cagrilintide?

Cagrilintide is a synthetic, lipidated and long-acting analogue of the pancreatic hormone amylin. It is being investigated in scientific and clinical research involving appetite regulation, metabolic signaling and body-weight management pathways.

Is Cagrilintide an approved medicine?

No. Cagrilintide remains an investigational compound. This FDPBIO product is supplied only as a laboratory research material and is not offered as a medicine.

How much Cagrilintide is supplied?

Each vial contains 5 mg of lyophilized Cagrilintide. One complete kit contains 10 vials.

What is the product code?

The product code is CGL5.

What is the CAS number?

The CAS number listed for Cagrilintide is 1415456-99-3.

What is the physical form?

The product is supplied as a white to off-white lyophilized powder.

What is the purity?

Purity is reported on the Certificate of Analysis for the specific manufacturing batch. Buyers should use the batch-specific COA as the controlling quality document.

Is a Certificate of Analysis available?

Batch-specific analytical documentation can be supplied subject to product availability and company documentation procedures.

Can this product be used in humans or animals?

No. It is strictly limited to laboratory research and is not intended for human or veterinary administration.

Can FDPBIO provide reconstitution or dosing instructions?

No clinical dosing or administration guidance is provided because this material is not intended for human or veterinary use. Laboratory procedures must be developed and approved by the purchaser’s qualified research team.

How should Cagrilintide be stored?

Follow the storage conditions printed on the product label and stated in the batch-specific Certificate of Analysis. Protect the lyophilized material from moisture, light and unnecessary temperature changes.

Can international buyers order Cagrilintide?

Availability depends on destination-country regulations, import requirements and internal compliance review. Buyers are responsible for verifying local legal requirements before ordering.

Scientific References

1. Kruse T, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry. 2021.

2. Lau DCW, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity. The Lancet. 2021.

3. ClinicalTrials.gov. Study NCT03856047.

4. PubChem. Cagrilintide compound record.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE.